Finance

Lists
Why is STLN down 6.53%?
Dive Deeper
STLN:NASDAQ
Starling Oncology, Inc.
$3.50
-6.53%
(-0.24) 1D
Nov 13, 11:33:34 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for STLN...
Open
$3.76
High
$4.24
Low
$3.30
Mkt. cap
357.99M
Avg. vol.
2.70M
Volume
8.06M
52-wk high
$7.13
52-wk low
$3.30
EPS
-$0.31
Beta
0.38
Shares outstanding
101.99M
No. of employees
641
Open
$3.76
High
$4.24
Low
$3.30
Mkt. cap
357.99M
Avg. vol.
2.70M
Volume
8.06M
52-wk high
$7.13
52-wk low
$3.30
EPS
-$0.31
Beta
0.38
Shares outstanding
101.99M
No. of employees
641
News stories
From web sources and news partners
About Starling Oncology, Inc.
CEO-
Employees641
Founded2007
HeadquartersCerritos, California, United States
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 4 analysts giving stock ratings to STLN in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for STLN in the last 3 months.
Highest
Current $3.50
$10.00 (+185.31%)
Average
$9.25 (+163.91%)
Lowest
$8.00 (+128.25%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Larsen
BTIG
Buy
Maintained
$10.00
+185.3%
11/09/2026
Yuan Zhi
B. Riley Securities
Buy
Maintained
$10.00
+185.3%
11/06/2026
Ben Haynor
Lake Street
Buy
Maintained
$8.00
+128.2%
11/06/2026
Matthew Shea
Needham
Buy
Reiterated
$9.00
+156.8%
10/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
141.96M
147.44M
161.28M
169.77M
Cost of goods sold
119.19M
124.13M
134.12M
139.10M
Cost of revenue
119.19M
124.13M
134.12M
139.10M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28.04M
28.21M
29.94M
32.13M
Operating expense
29.67M
29.83M
31.78M
33.65M
Total operating expenses
148.86M
153.95M
165.90M
172.75M
Operating income
-6.91M
-6.51M
-4.62M
-2.98M
Other non operating income
1.31M
5.96M
-3.31M
610.00K
EBT including unusual items
-7.51M
-2.49M
-9.79M
-15.75M
EBT excluding unusual items
-7.51M
-2.49M
-9.79M
-4.19M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.51M
-2.49M
-9.79M
-15.75M
Net profit margin
-5.29%
-1.69%
-6.07%
-9.28%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.92M
-1.93M
-1.86M
-1.82M
Net interest expenses
-1.92M
-1.93M
-1.86M
-1.82M
Depreciation and amortization charges
1.63M
1.62M
1.84M
1.52M
EBITDA
-5.28M
-4.90M
-2.78M
-1.46M
Gain or loss from assets sale
-
-
28.00K
119.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps